91 Results

People

  1. Motzer
    Motzer
  2. Makker
    Makker
  3. Abou-Alfa
    Abou-Alfa
  4. Drilon
    Drilon
  5. Lee
    Lee
  6. Voss
    Voss
  7. Wong
    Wong
  8. Aghajanian
    Aghajanian
  9. Carlo
    Carlo
  10. Konner
    Konner

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)
  7. Radiology, Department of (12)
  8. Gastrointestinal Oncology Service (11)
  9. Center for Pancreatic Cancer Research (9)
  10. Weinberg Fellows (9)
  1. "lenvatinib"
Formats
  1. Journal Article (58)
  2. Review (19)
  3. Editorial (3)
  4. Guidelines (3)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Meeting Abstract (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)

More Groups

People
  1. Robert Motzer (25)
  2. Vicky Makker (16)
  3. Ghassan Abou-Alfa (9)
  4. Chung-Han Lee (7)
  5. Alexander Drilon (4)
  6. Martin Voss (4)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Urology (5)
  2. Cancers (4)
  3. The Oncologist (4)
  4. Annals of Oncology (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Gastrointestinal Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. Elsevier Science, Inc. (8)
  3. Oxford University Press (8)
  4. MDPI (4)
  5. Nature Publishing Group (4)
  6. Wiley Blackwell (4)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LITESPARK-011: Belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy
    Review

    Motzer, R. J.; Schmidinger, M.; Eto, M.; Suarez, C.; Figlin, R.; Liu, Y.; Perini, R.; Zhang, Y.; Heng, D. Y. C.
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with advanced endometrial cancer treated with lenvatinib plus pembrolizumab or treatment of physician's choice
    Journal Article

    Lorusso, D.; Colombo, N.; Herraez, A. C.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy for metastatic clear cell renal cell carcinoma in patients treated with first-line immunotherapy combinations
    Research Letter

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • A phase Ib/II study of lenvatinib and pembrolizumab in advanced endometrial carcinoma (study 111/KEYNOTE-146): Long-term efficacy and safety update
    Journal Article

    Makker, V.; Aghajanian, C.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; Messing, M.; Dutta, L.; Dutcus, C. E.; Huang, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns and clinical outcomes for metastatic renal cell carcinoma in the current treatment era
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P. K.; Robert, N. J.; Vogelzang, N. J.; Perini, R. F.; Motzer, R. J.
    European Urology Open Science (2023)

    Fulltext@MSK | Save
  • Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma- A case report
    Journal Article

    El Dika, I.; Shia, J.; Chen, C. L.; Paroder, V.; Carver, A.; Shamseddine, A.; Mukherji, D.; Sirohi, B.; Makondi, P. T.; Asseily, C.; more...
    Journal of Gastrointestinal Oncology (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma
    Review

    Ged, Y.; Lee, C. H.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775
    Journal Article

    Yonemori, K.; Yunokawa, M.; Ushijima, K.; Sakata, J.; Shikama, A.; Minobe, S.; Usami, T.; Enomoto, T.; Takehara, K.; Hasegawa, K.; more...
    Cancer Science (2022)

    Fulltext@MSK | Save
  • Brief Report: Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy
    Journal Article

    Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Digumarthy, S. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
    Review

    Hasanov, E.; Yeboa, D. N.; Tucker, M. D.; Swanson, T. A.; Beckham, T. H.; Rini, B.; Ene, C. I.; Hasanov, M.; Derks, S.; Smits, M.; more...
    CA - A Cancer Journal for Clinicians (2022)

    Fulltext@MSK | Save